Cowen Financial Products LLC 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-13 12:22 pm Sale |
2024-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cowen Financial Products LLC | 1,909,228 4.900% |
-2,171 (-0.11%) |
Filing |
| 2024-02-02 12:40 pm Purchase |
2023-12-29 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cowen Financial Products LLC | 1,911,399 5.770% |
512,416 (+36.63%) |
Filing |
| 2023-05-05 3:28 pm Purchase |
2023-04-28 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
Cowen Financial Products LLC | 1,398,983 5.220% |
1,398,983 (New Position) |
Filing |